Azienda Ospedaliera-Ospedali Riuniti di Bergamo

Bergamo 24100

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Type 2 Diabetes Mellitus

Studies at this site

• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) — Completed